Dr. Paller will contribute as an investigator, collecting data for the registry. She also has been involved in several clinical trials (allantoin, diacerin, upcoming gene therapy studies). She has also referred several patients during the past year for other trials (eg U Minn, Stanford). She has participated in other studies of the natural course of EB and through the EBCRC.
|Effective start/end date||8/24/17 → 6/30/18|
- EB Research Partnership Inc. and the Epidermolysis Bullosa Medical Research Foundation (Agmt 1/12/18)